LBTN news just out very hot!
Lifeline Biotechnologies Prepares to File New Patent on Breast Cancer Detection
Mar 22, 2007 10:25:00 AM
Copyright Business Wire 2007
RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced that it is nearing a patent filing on its major breakthrough technology in the early detection of breast cancer.
Jim Holmes, CEO of Lifeline Biotechnologies, stated that "This technology advance has the potential of revolutionizing the way, timing and results this breakthrough holds in the assistance of detection of breast cancer. It means that, potentially, breast cancer could be identified in a greater number of patients, that is the accuracy could reduce the number of false positives and also reduce the number of needless biopsies. There are approximately 35 million mammograms a year in the United States. From which there are approximately one million biopsies. From this number of biopsies, approximately 200,000 to 250,000 cancers are identified. In other words, there are some 750,000 to 800,000 biopsies from which there are no cancers. We think our system has the potential of substantially reducing this number."